Bone Health and Menopausal Symptoms in Women After Oophorectomy
Author Information
Author(s): Challberg J, Ashcroft L, Lalloo F, Eckersley B, Clayton R, Hopwood P, Selby P, Howell A, Evans D G
Primary Institution: The University of Manchester
Hypothesis
Does hormone replacement therapy (HRT) usage affect bone health and menopausal symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy?
Conclusion
Women who do not take HRT after oophorectomy are at a higher risk of significant bone health issues.
Supporting Evidence
- 67% of women who had previously used HRT reported worse endocrine symptoms compared to current users.
- 58% of women experienced 24 months or more of oestrogen deprivation before age 50.
- 46% of women with significant oestrogen deprivation were found to have osteopenia or osteoporosis.
Takeaway
This study shows that women who have their ovaries removed early and don't take hormone therapy may have more problems with their bones and feel worse during menopause.
Methodology
The study reviewed responses from a questionnaire sent to women who underwent oophorectomy, assessing HRT usage, menopausal symptoms, and bone density.
Potential Biases
Women with greater concerns about bone health may have been more likely to respond to the questionnaire.
Limitations
The study is retrospective and relies on self-reported data, which may introduce recall bias.
Participant Demographics
Median age of responders was 50 years, with a range from 36 to 77 years; 76% had hysterectomy at the time of surgery.
Statistical Information
P-Value
P=0.006 for endocrine symptom scores between current and previous HRT users.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website